Esther Formula USA Corporation – Trademark Portfolio
Entity Type: 03
Esther Formula USA Corporation holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include NUTRIDIRECT and ESTHER FORMULA USA. The owner is based in Lakeport, CA.
4615 Work Right Circle
Lakeport, CA 95453
Showing of trademarks Trademarks
Trademark Classifications
Esther Formula USA Corporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Esther Formula USA Corporation have?
Esther Formula USA Corporation has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending, 2 abandoned.
What trademark classes does Esther Formula USA Corporation file in?
Esther Formula USA Corporation files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Esther Formula USA Corporation's most well-known trademarks?
Esther Formula USA Corporation's registered trademark portfolio includes well-known marks such as NUTRIDIRECT and ESTHER FORMULA USA. These are among 3 currently registered trademarks in the portfolio.
What is Esther Formula USA Corporation's trademark registration success rate?
Esther Formula USA Corporation has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 1 application is pending review.